540204 — Eiko Lifesciences Balance Sheet
0.000.00%
- IN₹725.28m
- IN₹664.04m
- IN₹279.29m
- 24
- 25
- 33
- 14
Annual balance sheet for Eiko Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.952 | 69.4 | 4.46 | 6.12 | 133 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | 34.1 | 45.6 | 71.1 | 131 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1 | 107 | 124 | 93 | 309 |
Net Property, Plant And Equipment | 3.09 | 2.48 | 143 | 139 | 136 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 57.6 | 166 | 349 | 310 | 527 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.842 | 39.6 | 60.1 | 12 | 15 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.8 | 40.9 | 62.6 | 16.2 | 20.6 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 54.8 | 125 | 286 | 294 | 507 |
Total Liabilities & Shareholders' Equity | 57.6 | 166 | 349 | 310 | 527 |
Total Common Shares Outstanding |